This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charter Medical To Be The Exclusive Distributor For CELLution Biotech In North America And The European Union

MANCHESTER, Conn., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Charter Medical, Ltd., a Lydall subsidiary, (NYSE:LDL) announced today that it has established a strategic partnership with CELLution Biotech B.V., an innovative developer and provider of bioreactors and fermenters based in the Netherlands. By combining their respective expertise in single-use technology and mass transfer, the partnership will provide customers in North America and Europe with turnkey single-use solutions for fermentation and perfusion cell growth.

CELLution Biotech's CELL-tainer ® products are used to perform high-density fermentation, making it the ideal tool for seed train development while operating in a single-use environment. CELLution Biotech's bioreactors can also be used in the application of mammalian cell culture perfusion given its superior mass transfer performance coupled with a unique channeling system.  This high level of performance enables the advantages of single-use technology to be applicable to the microbial fermentation and perfusion cell culture market segments where they are not commonly used today. 

Charter Medical, a Lydall company, will be the exclusive distributor of the CELL-tainer ® products as well as exclusive producer and supplier of Charter Medical's single-use bags utilized in conjunction with CELLution's systems.  Charter Medical will leverage its established customer relationships and strong network to sell these complementary products across North America and Europe.

Dale Barnhart, President and CEO of Lydall, stated:  "We are very excited about this opportunity as it takes advantage of Charter Medical's expertise in single-use products and helps transform our business into a more complete solution provider to the bioprocessing industry we currently serve today."

Hans Walraven, CEO of CELLution, commented that "CELLution is proud to enter this strategic alliance with such outstanding, complementary partners.  It certainly will boost the power of single-use solutions to our customers, in particular for new applications."

APIcells Inc. will complement the partnership between Charter Medical and CELLution by supporting the service of the systems as well as bringing additional upstream process engineering expertise, enabling customers to tailor the instrumentation and controls around the CELL-tainer ® technology and their process requirements.

About Lydall, Inc.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs